期刊： NEUROPSYCHOPHARMACOLOGY, 2021; 46 (10)
Broad-based cognitive deficits are an enduring and disabling symptom for many patients with severe mental illness, and these impairments are inadequat......
期刊： NEUROPSYCHOPHARMACOLOGY, ; ()
Schizophrenia is a complex disorder associated with aberrant brain functional connectivity. This study aims to demonstrate the relation of heterogeneo......
期刊： NEUROPSYCHOPHARMACOLOGY, ; ()
Patients with SCN8A epileptic encephalopathy exhibit a range of clinical features, including multiple seizure types, movement disorders, and behaviora......
期刊： NEUROPSYCHOPHARMACOLOGY, ; ()
The dorsal striatum (DS) is implicated in behavioral and neural processes including action control and reinforcement. Alcohol alters these processes i......
期刊： NEUROPSYCHOPHARMACOLOGY, ; ()
Anger is a common and debilitating symptom of post-traumatic stress disorder (PTSD). Although studies have identified brain circuits underlying anger ......
期刊： NEUROPSYCHOPHARMACOLOGY, ; ()
The goals of the current study were to determine whether topological organization of brain structural networks is altered in youth with bipolar disord......
期刊： NEUROPSYCHOPHARMACOLOGY, ; ()
Exposure to maltreatment during childhood is associated with structural changes throughout the brain. However, the structural differences that are mos......
期刊： NEUROPSYCHOPHARMACOLOGY, 2021; 46 (5)
Impaired glutamate homeostasis is a key characteristic of the neurobiology of drug addiction in rodent models and contributes to the vulnerability to ......
期刊： NEUROPSYCHOPHARMACOLOGY, 2020; 45 (7)
Genome-wide association studies (GWAS) have identified hundreds of genetic variants associated with schizophrenia (SCZ). However, prioritizing risk va......
期刊： NEUROPSYCHOPHARMACOLOGY, 2020; 45 (6)
Exosomal microRNAs (miRNAs) have been suggested to participate in the pathogenesis of neuropsychiatric diseases, but their role in major depressive di......
期刊： NEUROPSYCHOPHARMACOLOGY, 2020; 45 (6)
Cognitive control regulates cognitive and emotional systems to facilitate goal-directed behavior in the context of task-irrelevant distractors. Cognit......
期刊： NEUROPSYCHOPHARMACOLOGY, 2020; 45 (2)
Predicting the probability of converting from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is still a challenging task. This study aims......
期刊： NEUROPSYCHOPHARMACOLOGY, 2020; 45 (10)
The specific GluN2B antagonist rislenemdaz (Ris; a.k.a. MK-0657 and CERC-301) is in phase II clinical trial as an antidepressive drug, but the working......
期刊： NEUROPSYCHOPHARMACOLOGY, 2020; 45 (7)
Genome-wide association studies (GWAS) have reported substantial single-nucleotide polymorphisms (SNPs) associated with major depressive disorder (MDD......
